RYSTIGGO
As listed in the register: RYSTIGGO 140 mg/mL, solution injectable
140 mg · solution injectable
- Prescription only
- Active substance
- Rozanolixizumab
- Made by
- UCB PHARMA BELGIQUE
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
Netherlands1 matching products
Details
| Made by | UCB PHARMA BELGIQUE |
|---|---|
| Active substance | Rozanolixizumab |
| Strength | 140 mg |
| Form | solution injectable |
| Route | sous-cutanée |
| Dispensing (as stated by the register) | prescription réservée aux spécialistes et services NEUROLOGIE · médicament nécessitant une surveillance particulière pendant le traitement · prescription hospitalière · liste I · l'administration du 1 er cycle et de la 1 ère injection du 2 ème cycle doit être réalisée en milieu hospitalier |
| Marketed | Yes, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/23/1780 |
| Name in the register | RYSTIGGO 140 mg/mL, solution injectable |
| Packs | 1 flacon en verre de 2 mL · 1 flacon en verre de 3 mL · 1 flacon en verre de 4 mL |
| CIS | 68822785 |
| CIP13 | 3400930284742 |
| CIP13 | 3400930300763 |
| CIP13 | 3400930300770 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).